Strengths
NUVISAN has over 40 years of experience in the pharmaceutical and biotechnology sectors, establishing a strong reputation for reliability and expertise.
The company offers a comprehensive range of integrated services that cover the entire drug development lifecycle, from discovery to clinical trials.
NUVISAN's commitment to high-quality, tailored solutions allows it to meet the specific needs of diverse clients, including pharmaceutical companies and biotech startups.
The organization utilizes state-of-the-art technology platforms, enhancing its capabilities in drug discovery and development.
NUVISAN's positioning as a leading CRO/CDMO in Europe emphasizes its scientific excellence and integrated service offerings.
The company has a strong focus on personalized and flexible solutions, which fosters collaboration and efficiency for its clients.
NUVISAN's recent achievement as the first Gyrolab® Certified CRO in the EU showcases its commitment to innovation and quality in research.
The strategic acquisition by ALS Limited enhances NUVISAN's capabilities and expands its global network, providing access to additional resources and expertise.